Skip directly to content

Minimize RSR Award Detail

Research Spending & Results

Award Detail

Awardee:SUMAQ LIFE LLC
Doing Business As Name:SUMAQ LIFE LLC
PD/PI:
  • Norman P Reeves
  • (517) 316-6613
  • reevesn@icloud.com
Award Date:08/13/2020
Estimated Total Award Amount: $ 225,000
Funds Obligated to Date: $ 225,000
  • FY 2020=$225,000
Start Date:08/15/2020
End Date:07/31/2021
Transaction Type:Grant
Agency:NSF
Awarding Agency Code:4900
Funding Agency Code:4900
CFDA Number:47.041
Primary Program Source:040100 NSF RESEARCH & RELATED ACTIVIT
Award Title or Description:STTR Phase I: Remote patient monitoring of medication fall risk in the elderly
Federal Award ID Number:2013899
DUNS ID:080472408
Program:STTR Phase I
Program Officer:
  • Alastair Monk
  • (703) 292-4392
  • amonk@nsf.gov

Awardee Location

Street:712 AUDUBON RD
City:EAST LANSING
State:MI
ZIP:48823-3002
County:East Lansing
Country:US
Awardee Cong. District:08

Primary Place of Performance

Organization Name:SUMAQ LIFE LLC
Street:712 Audubon Road
City:East Lansing
State:MI
ZIP:48823-3002
County:East Lansing
Country:US
Cong. District:08

Abstract at Time of Award

The broader impact/commerical potential of this Small Business Innovation Research (SBIR) Phase I project will be a potentially significant reduction in medication-related falls, injuries, and deaths, as well as a reduction in fall-related medical costs. The number of older adults dying from falls increased by a factor of three between 2000 and 2016, with increased medication use possibly contributing to this alarming trend. Polypharmacy (i.e., taking 4 or more drugs) is growing with a 3-fold increase from 1992 to 2002. Since drugs are a modifiable risk factor, periodic medication reviews are recommended for fall prevention. This project will explore a new balance test involving target tracking to remotely monitor medication fall risk and allowing for timelier, personalized assessment of the risk of getting hurt. The Small Business Innovation Research (SBIR) Phase I project will advance a new balance test using target tracking. Technical work includes: 1) Confirm that the new test is sensitive to medication effects and is safe to perform; 2) Discriminate between fallers and non-fallers, thus demonstrating test validity; and 3) Compare test results with those of other tools. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

For specific questions or comments about this information including the NSF Project Outcomes Report, contact us.